Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy Barclays PLC

Start price
€51.48
15:00 / 50%
Target price
€63.65
21.02.27
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 21.02.27. The prediction end date can be changed by Barclays_PLC at any time.
Performance without dividends (%)
Name 1w
Bristol-Myers Squibb -
iShares Core DAX® 1.432%
iShares Nasdaq 100 1.892%
iShares Nikkei 225® -1.619%
iShares S&P 500 1.921%

Comments by Barclays_PLC for this prediction

In the thread Bristol-Myers Squibb diskutieren
Prediction Buy
Perf. (%) -
Target price 63.645
Change
Ends at 21.02.27

Bristol Myers Squibb (NYSE:BMY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $75.00 price target on the stock.
Ratings data for BMY provided by MarketBeat

Stopped prediction by Barclays_PLC for Bristol-Myers Squibb

Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€48.85
07.10.24
€39.19
07.10.25
-20.99%
08.10.25

Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€42.92
22.08.24
€37.80
22.08.25
-4.19%
23.08.25